We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+5.23%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$10.3M
(+10%)
Cap. Flow
+$6.19M
Cap. Flow
% of AUM
5.63%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
76
New
22
Increased
18
Reduced
15
Closed
9
Top Buys
| 1 |
IQVIA
IQV
|
+$1.81M |
| 2 |
MarineMax
HZO
|
+$1.77M |
| 3 |
Winnebago Industries
WGO
|
+$1.31M |
| 4 |
Pfizer
PFE
|
+$1.05M |
| 5 |
Cognyte Software
CGNT
|
+$984K |
Top Sells
| 1 |
Freeport-McMoran
FCX
|
+$2.65M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$2.48M |
| 3 |
Cytokinetics
CYTK
|
+$1.61M |
| 4 |
ARKO Corp
ARKO
|
+$1.53M |
| 5 |
Cohu
COHU
|
+$1.35M |
Sector Composition
| 1 | Healthcare | 31.09% |
| 2 | Technology | 10.92% |
| 3 | Materials | 10.24% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alico
ALCO
$303M
| $7.35M | 6.7% |
225,000
| – | – |
|
|
TGB
2
Trekor Metals
TGB
$2.72B
| $7.25M | 6.6% |
2,300,000
-150,000
| -6% | -$351K |
|
3
Rigel Pharmaceuticals
RIGL
$762M
| $4.68M | 4.26% |
250,000
| – | – |
|
4
Radiant Logistics
RLGT
$437M
| $4.56M | 4.15% |
750,000
-25,000
| -3% | -$150K |
|
5
Preformed Line Products
PLPC
$1.69B
| $4.47M | 4.08% |
28,000
| – | – |
|
6
BGC Group
BGC
$5.38B
| $3.58M | 3.26% |
350,000
+50,000
| +17% | +$459K |
|
7
Newmark Group
NMRK
$2.75B
| $3.34M | 3.04% |
275,000
| – | – |
|
8
inTEST
INTT
$184M
| $3.06M | 2.79% |
420,594
+45,594
| +12% | +$289K |
|
9
Warner Bros
WBD
$68.4B
| $2.87M | 2.61% |
250,000
+100,000
| +67% | +$933K |
|
|
FOLD
10
DELISTED
Amicus Therapeutics
FOLD
| $2.58M | 2.35% |
450,000
| – | – |
|
11
Talos Energy
TALO
$2.33B
| $2.54M | 2.32% |
300,000
-50,000
| -14% | -$401K |
|
12
Sabre
SABR
$696M
| $2.53M | 2.3% |
800,000
+100,000
| +14% | +$256K |
|
13
ClearPoint Neuro
CLPT
$470M
| $2.39M | 2.17% |
200,000
+25,000
| +14% | +$315K |
|
14
Republic Bancorp
RBCAA
$1.75B
| $2.34M | 2.13% |
32,000
-3,000
| -9% | -$205K |
|
|
15
ARKO Corp
ARKO
$864M
| $2.33M | 2.12% |
700,000
-350,000
| -33% | -$1.53M |
|
16
Park Hotels & Resorts
PK
$2.93B
| $2.3M | 2.1% |
225,000
+25,000
| +13% | +$255K |
|
17
Viatris
VTRS
$19.4B
| $2.23M | 2.03% |
250,000
+25,000
| +11% | +$211K |
|
18
Organon & Co
OGN
$3.54B
| $2.18M | 1.98% |
225,000
+75,000
| +50% | +$774K |
|
|
19
MarineMax
HZO
$766M
| $2.01M | 1.83% |
+80,000
| New | +$1.77M |
|
|
CGAU
20
Centerra Gold
CGAU
$3.12B
| $1.98M | 1.81% |
275,000
-75,000
| -21% | -$513K |
|
|
BRKL
21
DELISTED
Brookline Bancorp
BRKL
| $1.9M | 1.73% |
180,000
| – | – |
|
|
22
IQVIA
IQV
$34.5B
| $1.89M | 1.72% |
+12,000
| New | +$1.81M |
|
23
Ark Restaurants
ARKR
$20.7M
| $1.8M | 1.64% |
200,000
| – | – |
|
24
Atea Pharmaceuticals
AVIR
$389M
| $1.8M | 1.64% |
500,000
| – | – |
|
25
Coherus Oncology
CHRS
$222M
| $1.65M | 1.5% |
2,250,000
+102,500
| +5% | +$88.5K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM